Entry |
|
Symbol |
NFKBIE
|
Name |
NF-kappa-B inhibitor epsilon
|
Pathway |
map04658 | Th1 and Th2 cell differentiation |
map04660 | T cell receptor signaling pathway |
map04662 | B cell receptor signaling pathway |
map04920 | Adipocytokine signaling pathway |
map05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Disease |
|
Brite |
KEGG Orthology (KO) [BR:ko00001]
09150 Organismal Systems
09151 Immune system
04660 T cell receptor signaling pathway
K05872 NFKBIE; NF-kappa-B inhibitor epsilon
04658 Th1 and Th2 cell differentiation
K05872 NFKBIE; NF-kappa-B inhibitor epsilon
04659 Th17 cell differentiation
K05872 NFKBIE; NF-kappa-B inhibitor epsilon
04662 B cell receptor signaling pathway
K05872 NFKBIE; NF-kappa-B inhibitor epsilon
09152 Endocrine system
04920 Adipocytokine signaling pathway
K05872 NFKBIE; NF-kappa-B inhibitor epsilon
09156 Nervous system
04722 Neurotrophin signaling pathway
K05872 NFKBIE; NF-kappa-B inhibitor epsilon
09160 Human Diseases
09161 Cancer: overview
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
K05872 NFKBIE; NF-kappa-B inhibitor epsilon
09172 Infectious disease: viral
05169 Epstein-Barr virus infection
K05872 NFKBIE; NF-kappa-B inhibitor epsilon
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors
K05872 NFKBIE; NF-kappa-B inhibitor epsilon
Transcription factors [BR:ko03000]
Eukaryotic type
beta-Scaffold factors with minor groove contacts
RHR (Rel homology region) Ankyrin only
K05872 NFKBIE; NF-kappa-B inhibitor epsilon
|
Other DBs |
|
Genes |
» show all
|
Reference |
|
Authors |
Whiteside ST, Epinat JC, Rice NR, Israel A |
Title |
I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. |
Journal |
|
Sequence |
|